【レポートの概要（一部）】
01. Executive Summary
02.List of Abbreviations
03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05.Introduction
06.Disease Overview
06.1 Understanding the Disease
06.2 Pathophysiology
06.3 Epidemiology
06.4 Diagnosis
06.4.1 Immunohistochemistry
06.4.2 FISH
06.4.3 SPoT-Light HER2 CISH Test (Subtraction Probe Technology Chromogenic In Situ Hybridization)
06.4.4 Inform HER2 Dual ISH Test (Inform Dual In Situ Hybridization)
06.5 Management
06.5.1 Surgery
06.5.2 Radiotherapy
06.5.3 Chemotherapy
06.5.4 Targeted Therapy
06.5.5 Hormonal Therapy
06.6 Economic Burden
07.Pipeline Analysis
08.Market Landscape
08.1 Market Overview
08.2 Market Size and Forecast
08.3 HER-2 Positive Breast Cancer Market in US
08.3.1 Market Size and Forecast
08.4 HER-2 Positive Breast Cancer Market in EU
08.4.1 Market Size and Forecast
08.5 Five Forces Analysis
09.Market Segmentation by Type of Therapy
09.1 Chemotherapy
09.1.1 Alkylating agents
09.1.2 Antimetabolites
09.1.3 Cytotoxic antibiotics
09.1.4 Taxanes
09.2 Targeted Therapy
09.3 Hormone Therapy
10.Market Segmentation by Molecule Type
10.1 Biologics
10.2 Small Molecules
11.Market Segmentation by Route of Administration
11.1 Oral
11.2 Parenteral
12.Geographical Segmentation
13.Buying Criteria
14.Market Growth Drivers
15.Drivers and their Impact
16.Market Challenges
17.Impact of Drivers and Challenges
18.Market Trends
19.Trends and their Impact
20.Vendor Landscape
20.1 Competitive Scenario
20.1.1 Key News
20.1.2 Mergers and Acquisitions
20.2 Market Share Analysis 2014
20.2.1 Competitive Assessment of the Top Drugs
20.2.2 Celgene
20.2.3 F. Hoffmann-La Roche
20.2.4 GlaxoSmithKline
20.2.5 Novartis
20.2.6 Sanofi
20.3 SWOT Analysis of the Targeted Therapies
20.3.1 Herceptin
20.3.2 Kadcyla
20.3.3 Perjeta
20.3.4 Tykerb
20.4 Other Prominent Vendors
21.Key Vendor Analysis
21.1 Celgene
21.1.1 Key Facts
21.1.2 Business Overview
21.1.3 Business Strategy
21.1.4 Business Segmentation by Revenue
21.1.5 Sales by Geography
21.1.6 Key Information
21.1.7 SWOT Analysis
21.2 F. Hoffmann-La Roche
21.2.1 Key Facts
21.2.2 Business Overview
21.2.3 Business Segmentation
21.2.4 Business Segmentation by Revenue 2012 and 2013
21.2.5 Sales by Geography
21.2.6 Business Strategy
21.2.7 Key Information
21.2.8 SWOT Analysis
21.3 GlaxoSmithKline
21.3.1 Key Facts
21.3.2 Business Overview
21.3.3 Business Segmentation
21.3.4 Business Segmentation by Revenue 2012 and 2013
21.3.5 Sales by Geography
21.3.6 Pipeline Products
21.3.7 Business Strategy
21.3.8 Key Information
21.3.9 SWOT Analysis
21.4 Novartis
21.4.1 Key Facts
21.4.2 Business Description
21.4.3 Business Segmentation
21.4.4 Revenue by Business Segmentation
21.4.5 Revenue Comparison 2012 and 2013
21.4.6 Sales by Geography
21.4.7 Business Strategy
21.4.8 Key Developments
21.4.9 SWOT Analysis
21.5 Sanofi
21.5.1 Key Facts
21.5.2 Business Description
21.5.3 Business Segmentation
21.5.4 Revenue by Business Segmentation
21.5.5 Revenue Comparison 2012 and 2013
21.5.6 Sales by Geography
21.5.7 Business Strategy
21.5.8 Key Developments
21.5.9 SWOT Analysis
22.Other Reports in this Series
[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: Executive Summary of Global HER-2 Positive Breast Cancer Market 2015-2019
Exhibit 3: Pathophysiology: HER-2 Positive Breast Cancer
Exhibit 4: Prevalence Data of HER-2 Positive Breast Cancer in the US, 2014
Exhibit 5: Diagnosis of HER-2 Positive Breast Cancer: IHC
Exhibit 6: Diagnosis of HER-2 Positive Breast Cancer: FISH
Exhibit 7: Management of HER-2 Positive Breast Cancer
Exhibit 8: ASCO Treatment Guidelines: HER-2 Positive Breast Cancer
Exhibit 9: Snapshot of Economic Burden of the HER-2 Positive Breast Cancer Market in US
Exhibit 10: Pipeline Snapshot: Combination Therapies
Exhibit 11: Pipeline Snapshot: Therapeutic Vaccines
Exhibit 12: Snapshot of Global HER-2 Positive Breast Cancer Market 2014
Exhibit 13: Global HER-2 Positive Breast Cancer Market 2014-2019 (US$ million)
Exhibit 14: Drivers and Challenges of the Global HER-2 Positive Breast Cancer Market
Exhibit 15: HER-2 Positive Breast Cancer Market in US 2014-2019 (US$ million)
Exhibit 16: HER-2 Positive Breast Cancer Market in EU 2014-2019 (US$ million)
Exhibit 17: Global HER-2 Positive Breast Cancer Market Segmentation by Type of Therapy
Exhibit 18: Global HER-2 Positive Breast Cancer Market Segmentation by Type of Therapy 2014
Exhibit 19: Global HER-2 Positive Breast Cancer Market Segmentation by Molecule Type
Exhibit 20: Global HER-2 Positive Breast Cancer Market Segmentation by Molecule Type 2014
Exhibit 21: Global HER-2 Positive Breast Cancer Market Segmentation by Route of Administration
Exhibit 22: Global HER-2 Positive Breast Cancer Market Segmentation by Route of Administration 2014
Exhibit 23: Geographical Segmentation of Global HER-2 Positive Breast Cancer Market 2014
Exhibit 24: 5-Year Survival Rate by Stage of Diagnosis (SEER analysis for 2004-2010)
Exhibit 25: Revenue Comparison of Top Drugs for HER-2 Positive Breast Cancer in 2013 (US$ million)
Exhibit 26: Product Portfolio: Celgene
Exhibit 27: YoY Growth Rate and Global Revenue of Abraxane 2010-2013 (US$ million)
Exhibit 28: Product Portfolio: F. Hoffmann-La Roche
Exhibit 29: YoY Growth Rate and Revenue of Herceptin 2010-2013 (US$ million)
Exhibit 30: Revenue of Perjeta for 2012-2013 (US$ million)
Exhibit 31: YoY Growth Rate and Revenue of Xeloda 2010-2013 (US$ million)
Exhibit 32: Product Portfolio: GlaxoSmithKline
Exhibit 33: YoY Growth Rate and Revenue of Tykerb 2010-2013 (US$ million)
Exhibit 34: Product Portfolio: Novartis
Exhibit 35: YoY Growth Rate and Revenue of Femara 2010-2013 (US$ million)
Exhibit 36: Product Portfolio: Sanofi
Exhibit 37: YoY Growth Rate and Global Revenue of Taxotere 2010-2013 (US$ million)
Exhibit 38: Herceptin: SWOT Analysis
Exhibit 39: Kadcyla: SWOT Analysis
Exhibit 40: Perjeta: SWOT Analysis
Exhibit 41: Tykerb: SWOT Analysis
Exhibit 42: Celgene: Business Segmentation by Revenue 2011-2013 (US$ million)
Exhibit 43: Celgene: Sales by Geography 2013
Exhibit 44: Business Segmentation of F. Hoffmann-La Roche Ltd. 2013
Exhibit 45: F. Hoffmann-La Roche Ltd.: Business Segmentation by Revenue 2012 and 2013
Exhibit 46: F. Hoffmann-La Roche Ltd.: Sales by Geography 2013 (Pharmaceuticals Division)
Exhibit 47: F. Hoffmann-La Roche Ltd.: Sales by Geography 2013 (Diagnostics Division)
Exhibit 48: GlaxoSmithKline: Business Segmentation 2013
Exhibit 49: GlaxoSmithKline: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 50: GlaxoSmithKline: Sales by Geography 2013
Exhibit 51: GlaxoSmithKline: Pipeline Products 2013
Exhibit 52: Novartis AG: Business Segmentation
Exhibit 53: Novartis AG: Revenue by Business Segmentation 2013
Exhibit 54: Novartis AG: Revenue by Business Segmentation 2012 and 2013 (US$ million)
Exhibit 55: Novartis AG: Revenue by Geographical Segmentation 2013
Exhibit 56: Sanofi SA: Business Segmentation
Exhibit 57: Sanofi SA: Revenue by Business Segmentation 2013
Exhibit 58: Sanofi SA: Revenue by Business Segmentation 2012 and 2013 (US$ million)
Exhibit 59: Sanofi SA: Sales Revenue by Geographical Segmentation 2013
【レポート販売概要】
■ タイトル：HER2陽性乳がん治療の世界市場：化学療法、標的治療、ホルモン療法■ 英文：Global HER-2 Positive Breast Cancer Market 2015-2019
■ 発行日：2015年3月4日
■ 調査会社：Technavio
■ 商品コード：IRTNTR5462
■ 調査対象地域：グローバル
- 航空用高性能合金の世界市場：鉄基合金、コバルト基合金、ニッケル基合金About high performance alloys (HPAs) HPAs are alloys used in extremely high temperature applications (such as components of aircraft gas turbine engines). HPAs can mainly be classified into iron-based, cobalt-based, and nickel-based depending on the base element used. Technavio's analysts forecast the global aerospace high performance alloys market to grow at a CAGR of 6.05% over the period 2014-2 …
- Baytex Energy Corp.：石油・ガスの開発・生産動向及びコスト分析- Q2, 2013Baytex Energy Corp. Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary Baytex Energy Corp. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for …
- 患者用リフティング装置の世界市場予測（～2024年）“Increasing global geriatric & bariatric populations and the implementation of regulations is expected to drive the overall growth of the patient lifting equipment market” The patient lifting equipment market is expected to grow from USD 3.0 billion in 2019 to USD 5.4 billion by 2024, at a CAGR of 12.7% during the forecast period. The patient lifting equipment industry is driven primarily by the r …
- バックオフィス向けシステム統合ソリューションの世界市場About the Back Office System Integration MarketSystem integration solutions are used to integrate multiple systems, applications, and components in the information, communications, and technology (ICT) infrastructure of organizations. System integration solutions can be applied on the IT architecture of front office and back office to connect sub-systems and devices to exchange information within …
- High-Voltage Direct Current (HVDC) Converter Stations：グローバル市場規模、価格、市場シェア（～2020）High-Voltage Direct Current (HVDC) Converter Stations - Global Market Size, Average Pricing and Equipment Market Share to 2020 Summary “High-Voltage Direct Current (HVDC) Converter Stations - Global Market Size, Average Pricing and Equipment Market Share to 2020” is the latest report from GlobalData, the industry analysis specialists that offer comprehensive information and understanding of the ma …
- グローバルにおける自動車LED照明市場（2014-2018）About Automotive LED Lighting LED lighting, also known as solid-state lighting, is a semiconductor-based lighting technology. LED lights comprise lighting and signaling devices that are mounted or integrated to the exterior or interior of the vehicle. A lighting system provides vehicle safety and road illumination. It can also display information about the vehicle's presence, position, speed, size …
- グローバルコーヒー市場（～2019）The industry report Global Coffee Market to 2019 offers the most up-to-date market data on the actual market situation, and future outlook for coffee in the world. The research includes historic market data from 2008 to 2014 and forecasts until 2019 which makes the report an invaluable resource for industry executives, marketing, sales and product managers, analysts, and other people looking for k …
- 世界の高度CO2センサー市場動向（2012-2016）TechNavio's analysts forecast the Global Advanced CO2 Sensors market to grow at a CAGR of 32.5 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand for location-specific CO2 sensors. The Global Advanced CO2 Sensors market has also been witnessing the increasing institutional usage of CO2 sensors. However, the high cost of advanced CO …
- グルテンフリー食品のグローバル市場（2014-2018）About Gluten-free Food Gluten is a protein composite primarily found in wheat, barley, rye, and triticale. Gluten-free food is either free of ingredients that contain gluten or does not contain grains that are gluten rich. A gluten-free diet is the only medically recognized diet for patients suffering from celiac disease. Also, gluten-free food is healthy to consume and good for the digestive syst …
- ニコチン依存症(Nicotine Addiction)：世界の治験レビュー（2015年上半期版）Nicotine Addiction Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Nicotine Addiction Global Clinical Trials Review, H1, 2015" provides data on the Nicotine Addiction clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Nicotine Addiction. It includes an overview of the trial numbers and their recruitme …
- Mobile Devices and OS Comparative AnalysisDue to the rapid growth and evolution of the smart phone market, over the past few years, advances in network services drive the development of smart phones and drove the demand and popularity of smart phones. All smart phones come loaded with standard applications defined by the manufacturer. However, the network operators, looking for revenue opportunities, have encouraged the development of oth …
- Lung Injury：グローバル臨床試験レビューH1, 2013Lung Injury Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Lung Injury Global Clinical Trials Review, H1, 2013" provides data on the Lung Injury clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Lung Injury. It includes an overview of the trial numbers and their recruitment status as per the site of …
- バルブポジショナーの世界市場予測（～2024年）“The valve positioners market to exhibit significant growth from 2019 to 2024”The valve positioners market is expected to grow from USD 1.7 billion in 2019 to USD 2.2 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 5.3% during the forecast period. The growth of the market is driven by factors such as the increasing significance of control and monitoring in process industries and rising …
- 手術室用装置/用品の世界市場：麻酔機械、手術台、電気手術ユニット、マルチパラメータ患者モニタ、手術用画像デバイス、手術室照明The operating room equipment & supplies market is expected to reach USD 29.15 Billion in 2020 from USD 24.31 Billion in 2015, growing at a CAGR of 3.7%. The global market is segmented on the basis of product, type, and end user. By product, the market is categorized into operating room supplies and operating room equipment. The operating room supplies are estimated to account for the largest share …
- Surge Energy Inc.：石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Surge Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Surge Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key …
